Toxicity of interferon
- PMID: 6165428
- PMCID: PMC1504978
- DOI: 10.1136/bmj.282.6273.1345
Toxicity of interferon
Abstract
The effects of partially purified human leucocyte interferon (PIF) and of a preparation purified by passage twice through a monoclonal antibody affinity chromatography column (NK21F) were compared with those of a control solution in healhty volunteers. After intramuscular injections both interferon preparations caused rises in pulse rate and body temperature, changes in circulating white cell counts, and various unpleasant symptoms, the most common of which were headache, malaise, and fever. Slightly lower doses of NK21F were given, and this was reflected in lower peak serum concentrations. Mean symptom scores, however, were not lower after NK21F than after PIF. Local inflammatory reactions eight hours after intradermal inoculations of these interferons were similar. Purification of interferon using a monoclonal antibody does not reduce the facets of its activity considered in this study. They are therefore inherent in the leucocyte interferon type selected by the antibody.
Similar articles
-
Purification of human interferon by antibody affinity chromatography, using highly absorbed anti-interferon.Scand J Immunol. 1978;8(5):429-36. doi: 10.1111/j.1365-3083.1978.tb00538.x. Scand J Immunol. 1978. PMID: 725535
-
Interferon: pharmacokinetics and toxicity.Philos Trans R Soc Lond B Biol Sci. 1982 Sep 24;299(1094):91-107. doi: 10.1098/rstb.1982.0109. Philos Trans R Soc Lond B Biol Sci. 1982. PMID: 6183699
-
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies.Acta Virol. 1976 Aug;20(4):326-33. Acta Virol. 1976. PMID: 9822
-
Purification of human interferons by antibody affinity chromatography.Tex Rep Biol Med. 1977;35:187-92. Tex Rep Biol Med. 1977. PMID: 358447 Review.
-
Stabilization of interferons.Tex Rep Biol Med. 1977;35:198-204. Tex Rep Biol Med. 1977. PMID: 29357 Review.
Cited by
-
Interferons, a group of multiple lymphokines.Springer Semin Immunopathol. 1984;7(4):347-74. doi: 10.1007/BF00201966. Springer Semin Immunopathol. 1984. PMID: 6084313 Review. No abstract available.
-
A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer.Cancer Chemother Pharmacol. 1986;18(1):63-8. doi: 10.1007/BF00253067. Cancer Chemother Pharmacol. 1986. PMID: 3093108
-
Interferon therapy and immunity.J R Soc Med. 1983 Mar;76(3):230-3. doi: 10.1177/014107688307600319. J R Soc Med. 1983. PMID: 6187920 Free PMC article. No abstract available.
-
Response of differentiated but not anaplastic teratoma to interferon.Br J Cancer. 1984 Nov;50(5):611-6. doi: 10.1038/bjc.1984.227. Br J Cancer. 1984. PMID: 6498061 Free PMC article.
-
Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus.Antimicrob Agents Chemother. 1988 Apr;32(4):589-91. doi: 10.1128/AAC.32.4.589. Antimicrob Agents Chemother. 1988. PMID: 3377468 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources